Cargando…

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until Jun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arastehfar, Amir, Carvalho, Agostinho, van de Veerdonk, Frank L., Jenks, Jeffrey D., Koehler, Philipp, Krause, Robert, Cornely, Oliver A., S. Perlin, David, Lass-Flörl, Cornelia, Hoenigl, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346000/ https://www.ncbi.nlm.nih.gov/pubmed/32599813 http://dx.doi.org/10.3390/jof6020091

Ejemplares similares

Diagnosing COVID-19-associated pulmonary aspergillosis
por: Verweij, Paul E, et al.
Publicado: (2020)

Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis
por: Tavakoli, Mahin, et al.
Publicado: (2020)

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
por: Hoenigl, Martin, et al.
Publicado: (2021)

Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
por: Arastehfar, Amir, et al.
Publicado: (2020)

A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data
por: Lass-Flörl, Cornelia, et al.
Publicado: (2022)

Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp.
por: Stemler, Jannik, et al.
Publicado: (2023)

COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Dimopoulos, George, et al.
Publicado: (2021)

Aspergillus fumigatus and aspergillosis: From basics to clinics
por: Arastehfar, A., et al.
Publicado: (2021)

COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
por: Arastehfar, Amir, et al.
Publicado: (2020)

COVID-19-associated pulmonary aspergillosis (CAPA) might be associated with increased risk for pneumopleural fistula
por: Naendrup, Jan-Hendrik, et al.
Publicado: (2023)

Treatment of Aspergillosis
por: Jenks, Jeffrey D., et al.
Publicado: (2018)

324. COVID-19-Associated Pulmonary Aspergillosis (CAPA) at Veterans Affairs (VA) Hospitals in Southern California and Arizona
por: Fang, Michelle, et al.
Publicado: (2021)

Two cases of COVID‐19‐associated pulmonary aspergillosis (CAPA)
por: Lim, Jin Lee, et al.
Publicado: (2022)

Efficacy of LAMB against Emerging Azole- and Multidrug-Resistant Candida parapsilosis Isolates in the Galleria mellonella Model
por: Binder, Ulrike, et al.
Publicado: (2020)

COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report
por: Sharma, Avinash, et al.
Publicado: (2020)

COVID-19 associated pulmonary aspergillosis (CAPA) in a pregnant woman
por: Agrawal, Shruti, et al.
Publicado: (2021)

THE PANDEMIC'S FUNGAL REVENGE: COVID-19 ASSOCIATED PULMONARY ASPERGILLOSIS (CAPA)
por: PATEL, AZAD, et al.
Publicado: (2022)

1462 Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis in ICU patients: a multicenter study
por: Hoenigl, Martin, et al.
Publicado: (2014)

Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection
por: Jenks, Jeffrey D., et al.
Publicado: (2019)

Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study
por: Autier, Brice, et al.
Publicado: (2022)

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
por: Prattes, Juergen, et al.
Publicado: (2021)

The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
por: Arastehfar, Amir, et al.
Publicado: (2020)

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
por: Fekkar, Arnaud, et al.
Publicado: (2021)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Feys, Simon, et al.
Publicado: (2021)

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis – Authors' reply
por: Koehler, Philipp, et al.
Publicado: (2021)

Hypoxia Decreases Diagnostic Biomarkers for Aspergillosis In Vitro
por: Maurer, Elisabeth, et al.
Publicado: (2019)

Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
por: Thompson III, George R, et al.
Publicado: (2020)

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
por: Koehler, Philipp, et al.
Publicado: (2021)

P20 COVID-19-associated pulmonary aspergillosis (CAPA): review of utility of local CAPA guideline and MDT in directing diagnosis and antifungal stewardship
por: Hawkins, Lois, et al.
Publicado: (2022)

Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave
por: Bentvelsen, Robbert G., et al.
Publicado: (2022)

P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report
por: Sahoo, Asish, et al.
Publicado: (2022)

P170 Life threatening hemoptysis in COVID-19 associated Pulmonary Aspergillosis (CAPA)
por: Soman, Rajeev, et al.
Publicado: (2022)

405. Incidence and Potential Risk Factors of COVID-19 Associated Pulmonary Aspergillosis (CAPA)
por: Imoto, Waki, et al.
Publicado: (2023)

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
por: Jenks, Jeffrey D, et al.
Publicado: (2018)

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
por: Verweij, Paul E., et al.
Publicado: (2021)

Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients
por: Eigl, Susanne, et al.
Publicado: (2015)

Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review
por: Chong, W.H., et al.
Publicado: (2021)

Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Ruiz-Ruigómez, María, et al.
Publicado: (2022)

Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis – CAPA
por: Cocio, Tiago Alexandre, et al.
Publicado: (2023)

COVID-19 associated pulmonary aspergillosis (CAPA) case series in NHS Greater Glasgow and Clyde (GGC)
por: Hassan, Shadin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8djag4all6i6c76kv16kqphbqf